Federal award
ABBOTT LABORATORIES INC.
W81XWH19C0071
Contract
Obligated and Ceiling
- Obligated (net)
- $37,550,664.39
- Ceiling (potential value, not spending)
- $48,418,678.44
- Current value
- $37,604,628.77
- Gross positive obligations
- $38,655,109.69
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT LABORATORIES INC. · L3AXXYLB3V56
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT LABORATORIES INC. · L3AXXYLB3V56
- Awarding agency
- Department of War · sub-agency 97DH · office HT9427
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W81XWH19C0071
- Award type code
- D
- Actions
- 40 · Feb 28, 2019 to Jun 25, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History40
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 25, 2026 | FY2026 | P00039 | B | −$53,964.38 | — |
| Apr 9, 2026 | FY2026 | P00038 | M | $0.00 | — |
| Apr 7, 2026 | FY2026 | P00037 | M | $0.00 | — |
| Aug 5, 2025 | FY2025 | P00036 | C | $126.17 | — |
| May 9, 2025 | FY2025 | P00035 | C | $907,000.00 | — |
| Mar 24, 2025 | FY2025 | P00034 | C | $235,000.00 | — |
| Dec 13, 2024 | FY2025 | P00033 | D | −$10,000.00 | — |
| Sep 13, 2024 | FY2024 | P00032 | D | −$15,323.72 | — |
| Sep 10, 2024 | FY2024 | P00031 | D | $871,533.94 | — |
| Jun 25, 2024 | FY2024 | P00030 | D | −$290,813.56 | — |
| Aug 9, 2023 | FY2023 | P00029 | B | $302,976.61 | — |
| Jun 8, 2023 | FY2023 | P00028 | C | $335,900.74 | — |
| Jan 24, 2023 | FY2023 | P00027 | M | $0.00 | — |
| Dec 20, 2022 | FY2023 | P00026 | C | $450,000.00 | — |
| Jul 27, 2022 | FY2022 | P00025 | C | $60,315.86 | — |
| Jun 28, 2022 | FY2022 | P00024 | C | $150,193.98 | — |
| May 19, 2022 | FY2022 | P00023 | C | $2,612,423.92 | — |
| May 4, 2022 | FY2022 | P00022 | C | $0.00 | — |
| Apr 7, 2022 | FY2022 | P00021 | C | $350,000.00 | — |
| Mar 31, 2022 | FY2022 | P00020 | C | $111,111.00 | — |
| Mar 18, 2022 | FY2022 | P00019 | C | $250,007.62 | — |
| Jan 28, 2022 | FY2022 | P00018 | C | $832,000.00 | — |
| Dec 20, 2021 | FY2022 | P00017 | B | $0.00 | — |
| Nov 30, 2021 | FY2022 | P00016 | C | $312,541.94 | — |
| Jul 30, 2021 | FY2021 | P00015 | G | $150,442.06 | — |
| Jul 9, 2021 | FY2021 | P00014 | M | $0.00 | — |
| Jun 17, 2021 | FY2021 | P00013 | B | $0.00 | — |
| Mar 19, 2021 | FY2021 | P00012 | C | $4,035,572.37 | — |
| Mar 10, 2021 | FY2021 | P00011 | C | $832,375.97 | — |
| Jan 14, 2021 | FY2021 | P00010 | B | $0.00 | — |
| Dec 10, 2020 | FY2021 | P00009 | C | $1,423,724.69 | — |
| Dec 1, 2020 | FY2021 | P00008 | C | −$734,343.64 | — |
| Jun 26, 2020 | FY2020 | P00007 | C | $998,193.99 | — |
| Mar 26, 2020 | FY2020 | P00006 | C | $2,906,941.95 | — |
| Feb 28, 2020 | FY2020 | P00005 | C | $976,048.96 | — |
| Jan 29, 2020 | FY2020 | P00004 | C | $995,000.00 | — |
| Dec 4, 2019 | FY2020 | P00003 | M | $3,955,677.92 | — |
| Jun 5, 2019 | FY2019 | P00002 | M | $0.00 | — |
| May 24, 2019 | FY2019 | P00001 | C | $2,600,000.00 | — |
| Feb 28, 2019 | FY2019 | 0 | — | $12,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.